Literature DB >> 2156920

Pro-gamma-MSH levels in various disorders of pituitary-adrenal axis.

M Boscaro1, P Giacomazzi, N Sonino, F Fallo, F Girard, X Bertagna, F Mantero.   

Abstract

N-Terminal (1-76) portion of proopiomelanocortin (hNT) was measured in normals, Addison's, Nelson's, Cushing's disease, and in dexamethasone suppressible hyperaldosteronism (DSH) by using a specific homologous RIA. Mean basal immunoreactive hNT level was 94.2 +/- 6 pg/ml (mean +/- SE) in normal subjects. In Cushing's disease hNT values were slightly but not significantly (121 +/- 26.5 pg/ml) higher. In patients with DSH the levels were within normal range while they were much higher in Addison's and Nelson's syndromes. A strong correlation was found between IR-hNT and ACTH in plasma of normal subjects and patients with different disorders of the pituitary-adrenal axis (r = 0.83, p less than 0.01). Corticotropin-Releasing-Hormone (CRH) test in Cushing's disease stimulated the release of both ACTH and IR-hNT, showing a slightly different pattern of secretion. Similar patterns of secretion were found for hNT and ACTH in various pituitary-adrenal abnormalities. Normal levels of hNT in DSH do not support a role of this peptide in the pathogenesis of the disorder. Measurement of hNT in plasma can provide an additional tool for the diagnosis of patients with various disorders of the hypothalamic-pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156920     DOI: 10.1007/BF03348575

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; M Nakamura; A C Chang; S N Cohen; S Numa
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  The missing fragment of the pro-sequence of human pro-opiomelanocortin: sequence and evidence for C-terminal amidation.

Authors:  N G Seidah; J Rochemont; J Hamelin; S Benjannet; M Chrétien
Journal:  Biochem Biophys Res Commun       Date:  1981-09-30       Impact factor: 3.575

3.  Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide.

Authors:  A C Chang; M Cochet; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

4.  Measurement of N-terminal (1-76) of human proopiomelanocortin in human plasma: correlation with adrenocorticotropin.

Authors:  J S Chan; N G Seidah; M Chrétien
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

5.  Biosynthesis and characterization of adrenocorticotropic hormone, alpha-melanocyte-stimulating hormone, and an NH2-terminal fragment of the adrenocorticotropic hormone/beta-lipotropin precursor from rat pars intermedia.

Authors:  C Gianoulakis; N G Seidah; R Routhier; M Chrétien
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

6.  Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.

Authors:  T Motomatsu; H Takahashi; H Ibayashi; M Nobunaga
Journal:  J Clin Endocrinol Metab       Date:  1984-09       Impact factor: 5.958

7.  Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth.

Authors:  P J Lowry; L Silas; C McLean; E A Linton; F E Estivariz
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

8.  Concomitant secretion of Y-MSH with ACTH and beta-endorphin in humans.

Authors:  K Nakao; S Oki; I Tanaka; Y Nakai; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

9.  Development of a radioimmunoassay for an amino-terminal peptide of pro-opiocortin containing the gamma-MSH region: measurement and characterization in human plasma.

Authors:  J Hope; S J Ratter; F E Estivariz; L McLoughlin; P J Lowry
Journal:  Clin Endocrinol (Oxf)       Date:  1981-09       Impact factor: 3.478

10.  In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone.

Authors:  C Rivier; M Brownstein; J Spiess; J Rivier; W Vale
Journal:  Endocrinology       Date:  1982-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.